FDA
approval
· 2022-05-26
FDA Approved: BUMETANIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
Summary
FDA approved Glenmark Pharmaceuticals USA's Original Application for bumetanide, authorizing the generic diuretic bumetanide for U.S. use.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUMETANIDE (BUMETANIDE)